Thomas P. Davis

Active 1978–2025

239
Papers
41,254
Citations
113
h-index
238
i10-index

Citations

Citations per year for Thomas P. Davis1905: 1 citations1979: 1 citations1980: 2 citations1981: 3 citations1982: 3 citations1983: 2 citations1985: 3 citations1986: 5 citations1987: 6 citations1988: 5 citations1989: 1 citations1990: 8 citations1991: 6 citations1992: 4 citations1993: 7 citations1994: 5 citations1995: 8 citations1996: 22 citations1997: 29 citations1998: 26 citations1999: 43 citations2000: 28 citations2001: 66 citations2002: 80 citations2003: 93 citations2004: 109 citations2005: 196 citations2006: 193 citations2007: 280 citations2008: 263 citations2009: 327 citations2010: 341 citations2011: 306 citations2012: 285 citations2013: 261 citations2014: 249 citations2015: 255 citations2016: 246 citations2017: 218 citations2018: 279 citations2019: 834 citations2020: 1,198 citations2021: 1,222 citations2022: 1,162 citations2023: 896 citations2024: 1,274 citations2025: 685 citations2026: 21 citations1906–1978: no citations, so these years are not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,159 citing papers, 24% of this breakdownChina: 2,204 citing papers, 16.8% of this breakdownUnited Kingdom: 718 citing papers, 5.5% of this breakdownAustralia: 699 citing papers, 5.3% of this breakdownGermany: 574 citing papers, 4.4% of this breakdownIndia: 508 citing papers, 3.9% of this breakdownItaly: 413 citing papers, 3.1% of this breakdownCanada: 352 citing papers, 2.7% of this breakdownFrance: 338 citing papers, 2.6% of this breakdownSouth Korea: 301 citing papers, 2.3% of this breakdownSpain: 293 citing papers, 2.2% of this breakdownJapan: 277 citing papers, 2.1% of this breakdown
0%24%Other 25.1%

Fields

  • Medicine29.9%
  • Biochemistry, Genetics and Molecular Biology19.7%
  • Neuroscience16.6%
  • Materials Science12.7%
  • Chemistry7.2%
  • Engineering5.7%
  • Other8.2%

Topics

  • Barrier Structure and Function Studies4.5%
  • Nanoparticle-Based Drug Delivery3.9%
  • Alzheimer's disease research and treatments3.2%
  • RNA Interference and Gene Delivery2.8%
  • Neuroinflammation and Neurodegeneration Mechanisms2.7%
  • Nanoplatforms for cancer theranostics2.2%
  • Other80.7%

Coauthors

All papers

Open in search
  1. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

    Authors: , - Pharmacological Reviews 2005 cited by 2,633

  2. Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders

    Authors: , , , - Frontiers in Physiology 2020 cited by 429

  3. Regulation of blood–brain barrier integrity by microglia in health and disease: A therapeutic opportunity

    Authors: , - Journal of Cerebral Blood Flow & Metabolism 2020 cited by 379

  4. Half a century of amyloids: past, present and future

    Authors: , , , , , , , , , , , , , , - Chemical Society Reviews 2020 cited by 577

  5. Vascular dysfunction—The disregarded partner of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zvonimir S. Katušić, Sarah E. Lutz, Orly Lazarov, Richard D. Minshall, Jalees Rehman, Thomas P. Davis, Cheryl L. Wellington, Hector M. González, Chun Yuan, Samuel N. Lockhart, Timothy M. Hughes, Christopher Chen, Perminder S. Sachdev, John T. O’Brien, Ingmar Skoog, Leonardo Pantoni, Deborah Gustafson, Geert Jan Biessels, Anders Wallin, Eric E. Smith, Vincent Mok, Adrian Wong, Peter Passmore, Frederick Barkof, Majon Muller, Monique M.B. Breteler, Gustavo C. Román, Édith Hamel, Sudha Seshadri, Rebecca F. Gottesman, Mark A. van Buchem, Zoe Arvanitakis, Julie A. Schneider, Lester R. Drewes, Vladimir Hachinski, Caleb E. Finch, Arthur W. Toga, Joanna M. Wardlaw, Berislav V. Zloković - Alzheimer s & Dementia 2019 cited by 723

  6. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases

    Authors: , , , , , , , , , , - Acta Biomaterialia 2021 cited by 260

  7. Magnetic iron oxide nanoparticles for brain imaging and drug delivery

    Authors: , , , , , , , - Advanced Drug Delivery Reviews 2023 cited by 225

  8. A Decade of the Protein Corona

    Authors: , , , , - ACS Nano 2017 cited by 646

  9. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics

    Authors: , , , , , , , , , , , , , , , , , , - ACS Nano 2018 cited by 385

  10. Minimum information reporting in bio–nano experimental literature

    Authors: , , , , , , , , , , , , , , , , , , - Nature Nanotechnology 2018 cited by 639

  11. Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 156

  12. Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernst J. Wolvetang - Nature Aging 2023 cited by 66

  13. Implications of peptide assemblies in amyloid diseases

    Authors: , , , , , , , - Chemical Society Reviews 2017 cited by 325

  14. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Nanotechnology 2019 cited by 161

  15. The importance of nanoparticle shape in cancer drug delivery

    Authors: , , , - Expert Opinion on Drug Delivery 2014 cited by 577

  16. Oxidative Stress Increases Blood–Brain Barrier Permeability and Induces Alterations in Occludin during Hypoxia–Reoxygenation

    Authors: , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2010 cited by 327

  17. Biologically Targeted Magnetic Hyperthermia: Potential and Limitations

    Authors: , , , , , , , , - Frontiers in Pharmacology 2018 cited by 486

  18. Distribution of insulin in trigeminal nerve and brain after intranasal administration

    Authors: , , , - Scientific Reports 2019 cited by 138

  19. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy

    Authors: , , , , , , , , , , , - Nature Communications 2019 cited by 189

  20. Endothelial leakiness elicited by amyloid protein aggregation

    Authors: , , , , , , , , , , - Nature Communications 2024 cited by 42

  21. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nigel Turner, Minoti V. Apte, Thomas P. Davis, Jennifer P. Morton, Koroush S. Haghighi, Jorjina Kasparian, Benjamin J. McLean, Yordanos F. Setargew, Phoebe A. Phillips - Cancer Research 2021 cited by 132

  22. Star Polymers

    Authors: , , , , , , , , , - Chemical Reviews 2016 cited by 822

  23. Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier

    Authors: , , - Trends in Neurosciences 2001 cited by 775

  24. Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)

    Authors: , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2014 cited by 323